Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
LOW RISK
Score updated Aug 28, 2026

BLFS — BioLife Solutions, Inc. Dilution Risk Tracker

Track BLFS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLFS — Get alerts when the score changes →

As of August 28, 2026, BioLife Solutions, Inc. (BLFS) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. BioLife Solutions, Inc. has a market capitalization of $1.22B, 48.91M shares outstanding, 190 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BLFS.
🔔 Track BLFS — Get forecast alerts →

Market Data

Market Cap$1.22B
Shares Outstanding48.91M
Float42.84M
Cash$24.00M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 8.7% shares (2026Q1 vs prior)
190 institutional holders · 54.49M shares
#1 T. Rowe Price Investment Management, Inc. 6.51M shares
#2 BlackRock, Inc. 6.10M shares
#3 Casdin Capital, LLC 5.96M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.54M
Days to Cover2.1
% of Float10.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2017-12-31
4 INSIDER TRANSACTION 2026-04-10
4 INSIDER TRANSACTION 2026-04-10
4 INSIDER TRANSACTION 2026-04-10
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BLFS Dilution Snapshot

BioLife Solutions, Inc. (BLFS) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BLFS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLFS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BLFS
BLFS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.